SIPLIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 03:07:42 UTC 2023` Edited by `admin` on `Sat Dec 16 03:07:42 UTC 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED RAT
Sequence Type	UNKNOWN
Record UNII	KUW1QG1ZM3
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SIPLIZUMAB

Official Name

English

siplizumab [INN]

Common Name

English

MEDI-507

Code

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD2 (ANTIGEN)) (HUMAN-RAT MONOCLONAL MEDI-507 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RAT MONOCLONAL MEDI-507 LIGHT CHAIN, DIMER

Common Name

English

SIPLIZUMAB [USAN]

Common Name

English

Siplizumab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD2 (ANTIGEN)) (HUMAN-RAT MONOCLONAL MEDI-507 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-RAT MONOCLONAL MEDI-507 LIGHT CHAIN, DIMER

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

170603

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

FDA ORPHAN DRUG

116498

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

EU-Orphan Drug

EU/3/06/383

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

FDA ORPHAN DRUG

623917

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

FDA ORPHAN DRUG

107797

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

Code System Code Type Description

FDA UNII

KUW1QG1ZM3

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

INN

8251

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

EVMPD

SUB33504

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

CAS

288392-69-8

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

CHEMBL

CHEMBL2108742

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

WIKIPEDIA

SIPLIZUMAB

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

NCI_THESAURUS

C38685

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

USAN

NN-38

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

DRUG BANK

DB06371

Created by admin on Sat Dec 16 03:07:42 UTC 2023 , Edited by admin on Sat Dec 16 03:07:42 UTC 2023

PRIMARY

Related Record Type Details


					ZU51KFJ7F3

CD2

TARGET -> INHIBITOR

Related Record Type Details


					KUW1QG1ZM3

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:ESTIMATE	CHEMICAL